HIGHLIGHTS
- who: Balraj Singh and collaborators from the Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA have published the research: Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer, in the Journal: Cancers 2023, 2036 of /2023/
- what: To provide a proof of concept for the usefulness of the cell culture model for evaluating cancer therapies, in this study the authors evaluated a well-known BET bromodomain 3 of 14 inhibitor, JQ1, which has been shown . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.